Lobbying Governance
Overall Assessment | Analysis | Score |
---|---|---|
Limited |
SK Biopharmaceuticals affirms a public commitment to align its engagement with climate goals, noting that its “climate change strategy and scenario are based on the IPCC’s 1.5 degree special report” and that it has a “public commitment or position statement to conduct your engagement activities in line with the goals of the Paris Agreement.” However, the company does not disclose any formal governance process for its lobbying activities, as there is no description of how engagement is reviewed or managed, no oversight structures or named individual or committee responsible for ensuring alignment, and no specific mechanisms for monitoring direct or indirect lobbying in relation to its climate strategy.
View Sources
|
D |